Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation
  • Ask Questions

Hot topics

Share this:

  • LinkedIn
  • Facebook
  • Twitter
  • WhatsApp
  • Skype
  • Email

Like this:

Like Loading...

Recent Posts

  • Axsome Therapeutics’s SBECD-enabled AXS-07 Achieves Primary Endpoints and Prevents Migraine Pain Progression in Phase 3 Trial
  • Novartis CEO says Malaria drug biggest hope against coronavirus
  • EMA’s recommendation on compassionate use of SBECD-enabled remdesivir for COVID-19 and Update from Gilead
  • Race to find COVID-19 treatments accelerates
  • Special issue “Cyclodextrin-Based Drug Delivery System”

Tags

antibiotic Betadex Sulfobutyl Ether Sodium Biotechnology Book cancer Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Dexolve drug delivery Drugs Environment FDA Food HPBCD Nanoparticles nanotechnology Niemann Pick Niemann Pick Disease NPC Polymer remdesivir SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (4)
  • Analysis (9)
  • CD as API (49)
  • CD derivatives (65)
  • Cosmetics and toilettry (8)
  • Drug delivery (104)
  • E-ducation (26)
  • Environmental (23)
  • Events (73)
  • Food (34)
  • Gene delivery (5)
  • In Hungarian (1)
  • Non-pharma applications (61)
  • Other industrial use (23)
  • Pharma applications (181)
  • Supramolecular systems (7)
  • Uncategorized (9)

Top Posts

  • EMA's recommendation on compassionate use of SBECD-enabled remdesivir for COVID-19 and Update from Gilead
  • Novartis CEO says Malaria drug biggest hope against coronavirus
  • Race to find COVID-19 treatments accelerates
  • 10th Annual Congress of Nano Science and Technology-2020 (Nano S&T-2020)
  • Special issue "Cyclodextrin-Based Drug Delivery System"
  • CycloLab picks up the gauntlet to fight coronavirus
  • Gilead uses SBECD-enabled remdesivir (GS-5734) for treating the first case of the 2019 novel coronavirus in the United States
  • Axsome Therapeutics's SBECD-enabled AXS-07 Achieves Primary Endpoints and Prevents Migraine Pain Progression in Phase 3 Trial
  • Nasal delivery with beta-cyclodextrin is approved; a short story of Baqsimi
  • BIT’s 11th World Gene Convention-2020 postponed

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 217 other subscribers

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
%d bloggers like this: